These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2746853)

  • 41. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ampicillin-sulbactam.
    Dajani AS
    Pediatr Ann; 1993 Mar; 22(3):197-200. PubMed ID: 8464651
    [No Abstract]   [Full Text] [Related]  

  • 43. [Activity of an ampicillin/sulbactam combination in respiratory infections].
    Mangiarotti P; Manara G; Grassi G; Gialdroni Grassi G
    G Ital Chemioter; 1989; 36(1-3):39-44. PubMed ID: 2488911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical study of sultamicillin fine granules].
    Okada K; Kawakami K; Takeda E
    Jpn J Antibiot; 1988 Dec; 41(12):1954-8. PubMed ID: 3249368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on sultamicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1988 Dec; 41(12):1874-94. PubMed ID: 3249361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ampicillin/sulbactam--a combination of an old and a new agent in the treatment of infection.
    Kerins DM
    Am J Med Sci; 1991 Jun; 301(6):406-11. PubMed ID: 2039029
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacokinetics and clinical effects of sultamicillin fine granules in pediatrics].
    Morita H; Hisakawa H; Okada T; Kawakubo K; Kubota H; Hamada F; Tomoda T; Araki K; Tone Y; Wakiguchi H
    Jpn J Antibiot; 1988 Dec; 41(12):1973-9. PubMed ID: 3249371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
    Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
    Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-lactamase production and the role of ampicillin/sulbactam.
    Alpuche-Aranda CM
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S8-11; discussion S20-1. PubMed ID: 9519908
    [No Abstract]   [Full Text] [Related]  

  • 52. [The clinical and bacteriological efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating different infections].
    Strachunskiĭ LS; Novikova IuA; Prokhorenkov PI; Iakusheva LV
    Antibiot Khimioter; 1991 Jun; 36(6):18-21. PubMed ID: 1898183
    [No Abstract]   [Full Text] [Related]  

  • 53. [A clinical evaluation of sultamicillin fine granules in the treatment of meibomianitis].
    Ooishi M; Miyao M
    Jpn J Antibiot; 1988 Dec; 41(12):2059-64. PubMed ID: 3249376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical experience with cefoxitin in pediatric field (author's transl)].
    Okamoto T; Ohara K; Tomimatsu H; Hosoda T
    Jpn J Antibiot; 1981 Mar; 34(3):352-8. PubMed ID: 7289027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of lower respiratory tract infections with sultamicillin.
    Tageldin MA; Said A
    J Int Med Res; 1992; 20 Suppl 1():44A-52A. PubMed ID: 1451929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sulacillin in the treatment of bronchopulmonary diseases].
    Orlov VA; Sokolova VI; Sarsenbaeva DI; Manuĭlov KK
    Antibiot Khimioter; 1994; 39(2-3):45-8. PubMed ID: 7979795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical experience with ceftizoxime in the pediatric field (author's transl)].
    Hosoda T; Tomimatsu H; Ohara K; Okamoto T
    Jpn J Antibiot; 1982 Jan; 35(1):81-90. PubMed ID: 6279915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [An open non-comparative study of the efficacy and tolerability of sultamicillin in the therapy of respiratory infections in childhood].
    Cocchi C; Seracini D; Bartolozzi G
    Clin Ter; 1992 Sep; 141(9):183-6. PubMed ID: 1458803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillin.
    De Simone C; Trinchieri V; Tzantzoglou S; Famularo G; Moretti S; Delia S
    J Chemother; 1992 Dec; 4(6):376-80. PubMed ID: 1287139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.